Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Kedudukan dalam Saham #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Harga Saham
$484.33
Modal Pasaran
$379.69B
Perubahan (1 hari)
1.03%
Perubahan (1 tahun)
46.81%
Negara
CH
Perdagangan Roche Holding AG (RO)

Kategori

Healthcare
Nisbah P/S bagi Roche Holding AG (RO)
Nisbah P/S pada September 2026 TTM: 4.17
Menurut laporan kewangan dan harga saham terkini Roche Holding AG, nisbah P/S semasa (TTM) ialah 4.17. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Roche Holding AG dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 222.49%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 57.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 72.19%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 29.18%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 32.37%
CH